| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,597 | 8,313 | 7,498 | 8,253 | | Cost of Revenue | 4,881 | 3,906 | 3,798 | 4,773 | | | Gross Profit | 3,716 | 4,407 | 3,701 | 3,480 | | | Operating Expenses | | Research Development | 311 | 337 | 202 | 192 | | Selling General and Administrative | 5,043 | 6,931 | 6,700 | 8,338 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,638) | (2,861) | (3,201) | (5,049) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 275 | 835 | 96 | 24 | | Earnings Before Interest And Taxes | (3,102) | (2,026) | (3,105) | (5,025) | | Interest Expense | (1,090) | 683 | 407 | 296 | | Income Before Tax | (2,011) | (2,709) | (3,512) | (5,321) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,011) | (2,709) | (3,512) | (5,321) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (33) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,222 | (2,709) | (3,512) | (5,354) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,222 | ($2,709) | ($3,512) | ($5,354) |
|
0.02% Nasdaq 0.00%
Income Statement
